Jarun Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 2.00 Cr
as on 16-11-2024
- Company Age 17 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 6.50 Cr
as on 16-11-2024
- Revenue 11.93%
(FY 2023)
- Profit 81.81%
(FY 2023)
- Ebitda 6.50%
(FY 2023)
- Net Worth 0.41%
(FY 2023)
- Total Assets 12.56%
(FY 2023)
About Jarun Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company has closed loans amounting to ₹6.50 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Harshul Parikh, Umakant Parikh, and Hiren Parikh serve as directors at the Company.
- CIN/LLPIN
U24239GJ2007PTC051143
- Company No.
051143
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jun 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Jarun Pharmaceuticals Private Limited offer?
Jarun Pharmaceuticals Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops, Digestive System Drugs & Medicines, Antacid Drugs.
Who are the key members and board of directors at Jarun Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harshul Parikh  | Director | 20-Jun-2007 | Current |
| Umakant Parikh | Director | 20-Jun-2007 | Current |
| Hiren Parikh | Director | 04-May-2016 | Current |
Financial Performance of Jarun Pharmaceuticals.
Jarun Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11.93% increase. The company also saw a substantial improvement in profitability, with a 81.81% increase in profit. The company's net worth moved up by a moderate rise of 0.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jarun Pharmaceuticals?
In 2023, Jarun Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Lesion Care Private LimitedActive 15 years 9 monthsHarshul Parikh and Umakant Parikh are mutual person
- J J Parikh Pharma Pvt LtdActive 29 years 5 months
Harshul Parikh and Umakant Parikh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 03 Jan 2017 | ₹6.50 Cr | Satisfied |
How Many Employees Work at Jarun Pharmaceuticals?
Jarun Pharmaceuticals has a workforce of 96 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jarun Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jarun Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
